ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1336

Productivity Analysis in Patients with Idiopathic Inflammatory Myopathies and Relationship with Quality of Life and Emotional Domain: Preliminary Data from a Monocentric Cohort

Chiara Cardelli1, Michele Diomedi1, Simone Barsotti1, Alessandra Tripoli2, Linda Carli1 and Marta Mosca1, 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 2Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Vecchiano, Italy

Meeting: ACR Convergence 2022

Keywords: Disability, functional status, Myositis, Patient reported outcomes, quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Idiopathic Inflammatory Myopathies (IIM) are chronic diseases often causing disability in patients, associated with both disease activity and damage accrual. These conditions might reduce patients’ working ability, as well as significantly compromise their Quality of Life (QoL). To date, data on the productivity of IIM patients are scarce. The purpose of the study was to evaluate the impact of IIM on productivity both for working and extra-working activities, analysing any correlations with clinical picture, emotional conditions and QoL of patients.

Methods: Consecutive patients diagnosed with IIM (2017 EULAR/ACR criteria) followed at our Myositis Clinic from February to May 2022 were enrolled, collecting demographic and clinical data. The disease activity at the time of the assessment was determined using the specific items from the International Myositis Assessment and Clinical Studies Group. Productivity was assessed by administration of the Work Productivity and Activity Impairment Questionnaire (WPAI). Correlations with the Hospital Anxiety and Depression Scale (HADS) and generic Patient Reported Outcomes (PROs) were also analysed. Results were reported as mean±SD for continuous variables and as percentage for categorical variables. In the statistical analysis, p-value < 0.05 was considered significant.

Results: We included 45 patients (64.4% female, mean age 63.9 ± 14.1 years, mean disease duration 6.3 ± 5.3 years) with the following diagnoses: 24 dermatomyositis (DM, 53.3%), 17 polymyositis (37.9%), 2 amyopathic DM (4.4%), 1 juvenile DM (2.2%), 1 inclusion body myositis (2.2%). The 11 patients (24.4%) who had an occupation had a significantly lower mean age (p=0.008). The absenteeism and presenteeism rates were respectively 13.8% (±31.6) and 30% (±34.6), with an overall work impairment (OWI) of 35.6% (±39.1) and an activity impairment (AI) of 28.2% (±28.9). Patients with sicca symptoms had higher presenteeism rates (p< 0.001). Higher presenteeism and AI correlated positively with Patient Global Assessment (p≤0.002) and negatively with Manual Muscle Testing (p≤0.014); furthermore, AI correlated positively with the Health Assessment Questionnaire score (p< 0.001) and with the risk of anxiety and depression assessed by HADS (p≤0.001) and negatively with all domains related to physical and mental health of the Short-Form 36 (p≤0.002).

Conclusion: The data of our cohort, although preliminary, show significant levels of absenteeism and presenteeism and a significant impairment of both working and non-working productivity of IIM patients, with possible implications on the social cost of IIM. In particular, presenteeism seems to depend on the disease activity, while a reduced extra-work productivity seems to have a significant impact on the psychological sphere; both are associated with a worse QoL. Therefore, a better control of disease activity should be achieved to reduce patients’ disability, thus improving both their physical and emotional functioning.


Disclosures: C. Cardelli, None; M. Diomedi, None; S. Barsotti, None; A. Tripoli, None; L. Carli, None; M. Mosca, None.

To cite this abstract in AMA style:

Cardelli C, Diomedi M, Barsotti S, Tripoli A, Carli L, Mosca M. Productivity Analysis in Patients with Idiopathic Inflammatory Myopathies and Relationship with Quality of Life and Emotional Domain: Preliminary Data from a Monocentric Cohort [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/productivity-analysis-in-patients-with-idiopathic-inflammatory-myopathies-and-relationship-with-quality-of-life-and-emotional-domain-preliminary-data-from-a-monocentric-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/productivity-analysis-in-patients-with-idiopathic-inflammatory-myopathies-and-relationship-with-quality-of-life-and-emotional-domain-preliminary-data-from-a-monocentric-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology